Merck Profile

Performance

   

 Odds of Distress 

Check how we calculate scores
Equity ratings for Merck Co are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting April 19, 2019 and ending today June 18, 2019. Click here to learn more.
Merck Co cannot be verified against its exchange. Apparently, Merck is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Merck Co Income Statement Over Time

Direct Expenses    Consolidated Income    Cost of Revenue    

Merck Key Fundamentals

Merck Co cannot be verified against its exchange. Apparently, Merck is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 69000 people.. The public information regarding Merck Co's current market price is not available at this time.
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Merck SEC Filings
Merck SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameMerck Co
Chairman, CEO and PresKenneth FrazierView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
LocationNew Jersey U.S.A
Business Address2000 Galloping Hill Road
Foreign Associates
ExchangeBATS Exchange
CIK Number0000310158
ISINUS58933Y1055
CUSIP58933Y204
Prior SymbolSGP
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.merck.com
Phone908 740 4000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestApril 30, 2019

Merck Corporate Directors

Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director
Please see also Stocks Correlation. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Search macroaxis.com